Open AccessConversion Disorder in a Pharmacogenomics, Polypharmacy Patient: Case Report
Author(s) -
Michael J. Schuh,
Sheena Crosby
Publication year - 2021
Publication title -
innovations in pharmacy
Language(s) - English
Resource type - Journals
ISSN - 2155-0417
DOI - 10.24926/iip.v12i4.4034
Subject(s) - polypharmacy , pharmacogenomics , medicine , psychiatry , clinical pharmacy , medical diagnosis , neurology , patient care , family medicine , intensive care medicine , pharmacology , pharmacy , nursing , pathology
Background: Conversion disorder (CD) is a relatively common psychiatric disorder likely encountered by clinical pharmacists but probably not easily identified by pharmacists.Case Summary: This is a patient case where a patient with a tremor was referred to the pharmacist led, polypharmacy, pharmacogenomics (PGx) service to rule out a PGx cause due to medication metabolism. No pharmacologic or PGx cause was found for the tremor which helped support and confirm a diagnosis of CD.Practice Implications: By working collaboratively with psychiatrists, neurologists, physical medicine colleagues, clinical pharmacists may add value to patient care by assisting with diagnoses and appropriate treatment.